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The purpose of the current study was to determine whether suprathreshold doses of 
cocaine and morphine would combine in an additive fashion in the induction of 
behavioral sensitization. Therefore, rats were given one of four daily injections for 7 
days: vehicle, cocaine (IO mg/kg), morphine (2.5 mg/kg), or a cocaine/morphine 
combination (! 0 mg/kg, 2.5 mg/kg) and tested for locomotor activity. In addition, on 
the 8th day, all groups were given a challenge injection of cocaine (10 mg/kg) and 
tested for activity. The results indicated that animals that received cocaine showed a 
progressive increase in locomotor activity (i.e., mean distance traveled) over the 
seven days and a greater response to the cocaine challenge than the vehicle treated 
animals. In contrast, the group that received morphine did not show sensitization over 
the 7 day pretreatment phase. However, on the cocaine challenge day, this group did 
indeed show a greater response to cocaine as compared to the control group. More 
importantly, during the pretreatment phase, the addition of cocaine to morphine did 
not increase activity as compared to controls over the pretreatment phase. 
Additionally, on day 8, the combination of the two drugs did not significantly 
increase activity beyond either drug alone. Thus, the findings suggest that the 
combination of cocaine and morphine do not act in an additive manner. 
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CHAPTER 1 
INTRODUCTION 
I. Introduction to behavioral sensitization 
The abuse of psychostimulants ( e.g., cocaine, amphetamines, morphine, etc.) 
has become an increasing problem over the last two decades (Robinson & Becker, 
1986; Stewart & Badiani, 1993; Schifano, 1996). In humans, the acute administration 
of psychostimulant drugs produces an increase in arousal and states of euphoria. 
With repeated use, however, psychostimulants may produce an intense craving and a 
heightened sensitivity to other addictive drugs and drug-related stimuli. This 
increased sensitivity and craving often leads to compulsive drug seeking and drug 
taking behaviors (Schenk & Partridge, 1997; Robinson & Berridge, 2000; Robinson 
& Berridge, 2001 ). In addition, chronic psychostimulant abuse may also produce a 
variety of negative side effects such as anxiety, panic attacks, and schizophrenic-like 
psychoses (Robinson & Becker, 1986; Kalivas & Stewart, I 991; Robinson & 
Berridge, 1993). Although these negative side effects may subside if drug use is 
tenninated, they may resurface up to ten years later if drug use is reinstated (Kalivas 
& Stewart, 1991). Therefore, it appears that relatively permanent neurological 
changes occur after chronic psychostimulant abuse. 
In animals, intermittent injections of both direct (apomorphine) and indirect 
( e.g., cocaine, morphine, amphetamine) dopamine receptor agonists often produce a 
phenomenon known as behavioral sensitization that is characterized by a progressive 
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augmentation in a behavioral reaction ( e.g., locomotion, self-administration, etc.) to a 
drug with repeated administration. An important feature of sensitization is that it 
appears to be a relatively permanent effect (Mattingly, Gotsick, & Marin, 1988). For 
example, animals pretreated with psychostimulants can exhibit a heightened 
sensitivity to subsequent injections of psychostimulants after days, weeks, or even 
months of drug withdrawal (Henry & White, 1991; Kalivas & Duffy, 1987; 
Mattingly et al., 1988; Vanderschuren et al., 1999; Vanderschuren et al., 2000). 
Recent evidence suggests that behavioral sensitization develops to both the locomotor 
activating and reinforcing effects of most drugs (Mattingly et al., 1988; Kalivas & 
Duffy, 1987; Schenk & Partridge, 1997; Robinson & Becker, 1986; Robinson & 
Berridge, 1993; Stewart & Badiani, 1993). Thus, the sensitization observed in 
animals and the side effects of long-term psychostimulant abuse observed in humans 
may be related to a common neurobiological mechanism (see Robinson & Becker, 
1986; Kalivas & Stewart, 1991; Robinson & Berridge, 1993, for review). 
Consequently, a great deal of research has been directed at determining the 
neurobiological mechanisms mediating the development of behavioral sensitization. 
II. Relationship of the dopaminergic system to cocaine and /or opiate-induced 
behavioral sensitization 
Although behavioral stimulants affect a variety of neurochemical systems in 
the brain, the locomotor activating and reinforcing effects of behavioral stimulants are 
thought to be mediated by the dopaminergic system (see Robinson & Becker, 1986; 
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Kalivas & Stewart, 1991; Robinson & Berridge, 1993; Robinson & Berridge, 2000; 
Robinson & Berridge, 2001). 
The mesocorticolimbic system ( originating from the ventral tegmental area 
and projecting to the limbic system and pre-frontal cortex) is commonly associated 
with both the rewarding and locomotor activation aspects of drugs of abuse while the 
nigrostriatal system is associated with other motoric effects of these drugs (White, 
1996; Robinson & Berridge, 1993). 
Both the mesocorticolimbic and nigrostriatal system appear to play . a 
definitive role in both the development and persistence of behavioral sensitization to 
cocaine and morphine. Indeed, repeated cocaine or morphine treatments cause similar 
changes in both systems suggesting a common underlying neural mechanism 
responsible for the development of behavioral sensitization to these psychostimulants 
(Beitner-Johnson, Guitart, & Nestler, 1992). 
For example, chronic exposure to cocaine or morphine produces long-term 
adaptations in G-proteins, adenylyl cyclase activity, cAMP-dependent protein kinase, 
and tyrosine hydroxyla~e levels in the ventral tegmental area (VTA) and/or the 
nucleus accumbens (Beitner-Johnson, Guitart, & Nestler, 1992). Both chronic 
morphine and cocaine treatments increase the tyrosine hydroxylas_e level in the 
ventral tegmental area but have no effect in the nucleus accumbens, substantial nigra, 
or the caudate putamen. Th~ il')crease in tyrosine hydroxylase activity may reflect a 
common change in the ventral tegmental area and a general increase in VT A neuronal 
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activity (Beitner-Johnson et al., 1992). Indeed, neurochemical lesions of the VT A 
and/or the nucleus accumbens have been shown to disrupt both opiate and cocaine 
self-administration. Also, animals will self-administer these drugs into these brain 
regions suggesting a common mechanism within the mesocorticolimbic system 
mediating the rewarding aspect of cocaine and morphine (Beitner-Johnson et al.. 
1992). In addition, Kalivas and Duffy (1987) demonstrated that repeated injections of 
opioids into the A 10 dopamine region produce a dopamine dependent increase in 
motor activity. Daily intra-Al0 administration of opioids is associated with an 
augmented increase in dopamine metabolites in the nucleus accumbens. Therefore, 
changes in dopaminergic neurotransmission appear to be involved in mediating some 
of the behavioral effects of opioids. 
In addition to the mesocorticolimbic system, parts of the nigrostriatal system 
appear to play a significant role in the development of behavioral sensitization to 
cocaine or morphine. Chronic morphine has been shown to increase DOPAC levels, 
homovillic acid levels, and the dopamine turnover rate in the striatum (Airio & Ahtee, 
1997). Kalivas and Stewart (1991) demonstrated that behavioral sensitization to 
repeated administration of opioids related to the indirect stimulation of dopamine cell 
bodies in the VT A and the substantia nigra. 
Therefore, several common mechanisms appear to exist for the development 
of behavioral sensitization to either opiates or cocaine. 
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III. Relationship of dopamine receptors to cocaine and/or opiate-induced 
behavioral sensitization 
Although one line of research investigates the anatomical regions in relation to 
behavioral sensitization, another line of research studies the involvement of 
dopaminergic receptors in the development of behavioral sensitization. 
Recently, it has been discovered that dopamine (DA) receptors have five 
different subtypes, which are classified under the DI and D2 subfamilies depending 
upon the receptor's biochemical, molecular, and pharmacological properties (Sibley, 
Monsma, & Shen, 1993; O'Dowd, 1993). The DI subfamily includes the DI and D5 
receptor subtypes which, when activated, stimulate adenylate cyclase activity. The D2 
subfamily includes the D2, D3, and D4 receptor subtypes. The dopamine D2 
subfamily receptors do not promote or inhibit adenylate cyclase activity. 
Research has shown that most stimulant type drugs either directly or indirectly 
produce an overstimulation of DA receptors in both the DI and D2 receptor sub-
families (Ferger, Kropf, & Kuschinsky, 1994). In addition, a number of changes in 
dopamine receptor function have been reported following the chronic administration 
ofpsychostimulants in rats (Kalivas & Stewart, 1991). 
A supersensitivity has been reported in DI post-synaptic receptors following 
chronic cocaine administration (Henry, Green, & White, 1989; Henry & White, 
1991). Importantly, the DI supersensitivity is still apparent following several weeks 
of drug withdrawal (Henry & White, 1991). In addition, the co-administration of a 
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DI antagonist with cocaine decreases cocaine self-administration and prevents 
sensitization to the conditioned rewarding effects of cocaine (Caine & Koob, 1994, 
Shippenberg & Heidbreder, 1995). 
Unlike the supersensitivity found in the DI receptors, repeated cocaine 
treatments induce sub-sensitivity in dopamine D2 autoreceptors (Henry et al., I 989; 
Henry and White, 1991). However, this decrease in autoreceptor sensitivity is 
transient, lasting only a few days after drug withdrawal (Ackerman and White, 1990). 
It is also important to note that the co-administration of a D2 antagonist with cocaine 
has no effect on the self-administration or conditioned place preference to cocaine 
(Caine & Koob, 1994; Shippenberg & Heidbreder, 1995). Thus, it would appear that 
the DI receptor is the controlling factor in the development of behavioral sensitization 
to the rewarding effects to cocaine. However, recent evidence has demonstrated that 
neither the DI receptor nor the D2 receptor alone controls the development of 
behavioral sensitization to the locomotor stimulating effect of cocaine (Mattingly et 
al., 1994; White et al., 1998). 
In addition to cocaine, behavioral sensitization has been shown to develop · 
from the repeated administration of the mu opioid receptor agonist, morphine. 
Morphine-induced behavioral sensitization may be due to indirect stimulation of 
dopamine receptors leading to an increase in extracellular dopamine (Di Chiara & 
Imperato, 1988). Like cocaine sensitization, studies indicate that both DI and D2 
receptor stimulation is needed for the expression but not for the development of 
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behavioral sensitization to systemically administered morphine (Jeziorski & White, 
1995). Also, it has been shown that pretreatment with dopamine agonists can either 
enhance or reduce morphine-induced locomotion. For example, in mice, the intra-
cerebral co-administration of the Dl-agonist, SKF38393, increased morphine-induced 
locomotion by approximately 2-fold which was antagonized by the DI antagonist, 
SCH23390. On the contrary, the intra-cerebral co-administration of a low dose of the 
D2 agonist quinpirole, which may stimulate D2 autoreceptor activity, and morphine 
resulted in a reduction of morphine-induced locomotion (Funada, Suzuki, & Misawa, 
1994). In addition, withdrawal from repeated morphine increases the sensitivity of 
dopamine D2-like receptors (Piepponen et al., 1996). Therefore, dopamine receptors 
may play a role in the expression, acceleration, and overall increase in sensitivity to 
morphine (Jeziorski & White, 1995; Kuribura, 1995). 
IV. Cross-sensitization between cocaine and morphine 
Although most research has focused on the development of behavioral 
sensitization to the repeated administration of a single psychostimulant, several 
studies have either directly or indirectly investigated cross-sensitization. Cross-
sensitization is similar to behavioral sensitization in that there is an augmented 
response to a previous drug exposure. However, the difference between cross-
sensitization and behavioral sensitization is the animal shows an enhanced response to 
a drug due to previous exposure to different drug. For example, opioid and dopamine 
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agonists have been shown to enhance each other's locomotor activating and reward 
effects (Vanderschuren et al., 1997). 
In addition to locomotion, cross-sensitization to the rewarding effects of 
opioids and dopamine agonists has been demonstrated. For example, dopamine 
agonists (i.e., amphetamine and cocaine) and morphine were shown to cross-sensitize 
to each other in tasks measuring conditioned reward (Shippenberg & Heidbreder, 
1995; Venzina et al., 1989; Shippenberg, LeFevour, & Thompson, 1998; 
Cunningham & Kelley, 1992). 
In addition to cross-sensitivity between drugs, recent studies suggest that the 
combined administration of drugs of different classes, particularly dopamine agonists 
and opioid agonists, may increase the behavioral and rewarding aspects of these drugs 
in an additive or supra-additive way. Recently, the combination of cocaine with 
morphine or heroin, commonly known as "speedball", has received a great amount of 
attention. Several studies have investigated "speedball" and have produced 
conflicting results. For example, Mello et al. (1995) found that the effects of cocaine 
and heroin combinations on drug self-administration did not differ from that of either 
drug alone. In contrast, several other studies have demonstrated that the "speedball" 
combination demonstrates an enhancement in the rewarding effects as compared to 
the rewarding effects of either drug alone (Rowlett & Woolverton, I 997; 
Duvauchelle, Sapoznik, & Kornetsky, 1998). The conflicting results between studies 
may reflect differences in experimental design such as varying schedules of 
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reinforcement. 
In addition to the reinforcing aspects of "speedball", the locomotor effects of 
the cocaine and opioid agonist combinations have been investigated. Indeed, several 
studies have demonstrated that the "speedball' combination typically produces an 
enhanced acute locomotor response compared to that of either drug alone (Kunko, 
French, & Izenwasser, 1998; Kimmel & Holtzman, 1997; Kimmel, Tallarida, & 
Holtzman, 1997). 
Although opioid/cocaine combinations appear to enhance the acute locomotor 
activating effects of either drug, repeated treatments with morphine and cocaine do 
not appear to enhance the development of behavioral sensitization (Mattingly et al., 
1999). However, this latter study used doses of cocaine and morphine individually 
subthreshold for the development of behavioral sensitization. Consequently, whether 
high suprathreshold doses of cocaine and morphine would combine in an additive 
fashion in the development of behavioral sensitization is unknown. 
V. Purpose 
In summary, repeated treatments with either cocaine or morphine produce 
behavioral sensitization. In addition, cross-sensitization between these two dmgs has 
been reported. Further, the rewarding and acute locomotor effects appear to combine 
in an additive or supra-additive fashion. At present, the nature of the interaction 
between cocaine and opiates on the development of behavioral sensitization is 
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unclear. The purpose of the present study, therefore, was to determine whether 
suprathreshold doses of cocaine and morphine would combine in an additive fashion 
in the induction of behavioral sensitization. 
Consequently, groups of rats were given injections of vehicle, cocaine, 
morphine, or a cocaine/morphine combination every forty-eight hrs and then tested 
for locomotor activity. At the conclusion of this chronic pretreatment, all animals 
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Thirty-two adult male Wistar albino rats (Harlan Industries, Indianapolis, IN) 
weighing 250-300 grams served as subjects. All rats were individually housed in 
hanging wire-mesh cages in a temperature- controlled colony room with a 12 h 
light/dark cycle. Animals were given unrestricted access to food and water. All 
behavioral testing was conducted during the light phase of the cycle. 
Apparatus 
Activity measures were taken in four square (approximately 41 X 41 cm) open 
field test chambers (MED Associates, model OFA-163). The base of each chamber 
was 1.3 cm thick, white PVC. The sidewalls were 0.6cm clear acrylic with the 
corners reinforced by aluminum angle. The chambers were equipped with a 16X16 
array of infrared photocell beams located 2.5 cm above the floor and a single array of 
16 photocells IO cm above the floor. In addition, a clear acrylic cylinder ( 41 cm 
diameter) was placed inside each test chamber (see Figure I). 
Output from each photocell array was connected to a Gateway 2000 computer 
in an adjacent room through a MED Associates interface. Using MED Associates 
software, distance traveled (cm), stereotypic count (small movements), and vertical 




Figure I. Med-Associates locomotor activity chamber 
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Drugs 
Cocaine hydrochloride (N.I.D.A.) and/or Morphine sulfate (N.I.D.A.) were 
dissolved daily into distilled H2O and injected IP in a volume of 1.0 ml/kg. All doses 
were calculated based on salt weight of the drug. Vehicle injections were given using 
the same route and volume as the corresponding drug injection. 
Design and Procedure 
At the beginning of the experiment, the rats were randomly assigned to one of 
four groups (8 animals per group) comprising a two (vehicle vs. cocaine) X two 
(vehicle vs. morphine) factorial design. Therefore, the rats were divided into four 
pretreatment groups: vehicle/vehicle, vehicle/cocaine, morphine/vehicle, and 
morphine/cocaine (see Table 1). The experimental groups were counterbalanced 
between the four activity chambers (See Appendix A, Table 11 ). 
Table I. Experimental Design 
Experimental groups (2 X 2 factorial design) 
VEHICLE MORPHINE 
VEHICLE Vehicle (n = 8) Morphine (n = 8) 
COCAINE Cocaine (n = 8) Morphine/Cocaine (n = 8) 
The experiment was conducted in two phases: a pre-exposure phase and a 
cocaine sensitization test. During the pre-exposure phase of the experiment, rats were 
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injected with a single injection of vehicle, cocaine (10 mg/kg), morphine (2.5 mg/kg), 
or a cocaine/morphine (IO mg/kg, 2.5 mg/kg) cocktail. After the daily injection, each 
rat was given five min for the drug to take effect and then tested for locomotor 
activity for 120 min. This injection-test procedure was repeated every 48 hrs for a 
total of seven sessions. Twenty-four hrs after the last pre-exposure session, the 
cocaine sensitization test phase was initiated. During this test, all rats were given a I 0 
mg/kg iajection of cocaine, a 5 min waiting period, and then a 120 min sensitization 
test for locomotor activity. 
Data Analysis 
Each measure of motor activity was recorded in blocks of IO mm and 
analyzed using a mixed-factor analysis of variance with drug treatment conditions as 
between groups factors and activity test sessions and blocks of IO min within sessions 
as repeated measures. Significant interactions were analyzed with additional 
ANOV As performed on individual sessions and/or block data, followed by Neuman-
Keuls post hoc tests. 





The mean distance traveled in centimeters for each of the four pretreatment 
groups for the seven 120 min pretreatment sessions is illustrated in Figure 2. The 
within session activity across twelve 10 min blocks for the four pretreatment groups 
on Day 1, 4, and 7 is depicted in Figure 3. A mixed factor analysis of variance was 
performed on the mean distance traveled data with drug treatment conditions as 
between-groups factors and activity test sessions and blocks within sessions as 
repeated measures (See Appendix A, Table 2). 
As may be seen in Figure 2, overall rats treated with cocaine (i.e., Vehicle-
Cocaine group, Morphine-Cocaine group) were significantly more active than the 
vehicle treated rats (i.e., Vehicle-Vehicle group) across the pretreatment sessions, 
[cocaine effect: E(l, 28) = 33.41, g < .0001]. Moreover, as seen in Figures 2 and 3, 
this cocaine effect increased across days and was greatest during the first few blocks 
of each session [Cocaine x Day interaction: !:(6, 168) = 3.63, g < .01; Cocaine x 
Block interaction: !:(11, 308) = 48.15, g < .0001; Cocaine x Day x Block interaction: 
!:(66, 1848) = 2.72, g < .0001]. Similar to cocaine, rats pretreated with morphine 
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Figure 2. Mean distance traveled in cm (± SEM) for each of the four pretreatment 
groups over the seven 120 min pretreatment sessions. -a, 
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1 4 7 
BLOCKS OF 10 MINUTES WITHIN EACH SESSION 
Figure 3. Mean distance traveled in cm (±. SEM) for each of the four pretreatment groups across the 




.001]. However, morphine had a significantly greater overall effect on rats given 
vehicle than for rats pretreated with cocaine [Morphine x Cocaine interaction: f.(l, 
28) = 4. 74, _p_ < .05]. Indeed, for rats pretreated with vehicle, morphine significantly 
increased activity [Newman-Kuels, _p_ < .05]. However; morphine did not 
significantly increase activity for rats treated with cocaine suggesting that an additive 
effect does not exist between cocaine and morphine (i.e., Morphine-Cocaine group vs 
Vehicle-Cocaine group; Newman-Kuels, _p_ > .05]. 
Stereotypic Counts: 
The mean stereotypic counts for each of the four pretreatment groups for the 
seven 120 min pretreatment sessions is illustrated in Figure 4. The within session 
activity across twelve IO min blocks for the four pretreatment groups on days 1, 4, 
and 7 is depicted in Figure 5. A mixed factor analysis of variance was performed on 
the stereotypic counts data with drug treatment conditions as between-groups factors 
and activity test sessions and blocks within sessions as repeated measures (See 
Appendix A, Table 3). 
As illustrated m Figure 4, overall, rats pretreated with cocame were 
significantly more active than animals that did not receive cocaine [ cocaine effect: 
!:(1,28) = 41.08, _p_ < .0001] and this effect was more pronounced in the early blocks 
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Figure 4. Mean stereotypic counts for each of the four pretreatment groups over 





























1 4 7 
BLOCKS OF 10 MINUTES WITHIN EACH SESSION 
Figure 5. Mean stereotypic counts for each of the four pretreatment groups across the twelve 10 min 
blocks within each of the 120 min pretreatment sessions for days 1, 4, and 7. N 0 
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morphine also displayed increased stereotypy counts compared to vehicle treated 
animals over the seven days, particularly on the middle blocks of each session 
[morphine effect: !:(1, 28) = 19.72, 2 < .0001; Morphine X Block interaction: !:(11, 
308) = 2.20, 2 < .0 I]. However, cocaine did not increase stereotypy in morphine 
pretreated animals and morphine did not increases stereotypy in cocaine pretreated 
animals [Morphine x Cocaine interaction: !:(l, 28) = 8.87, 2 < .01; Newman-Kuels 
test, 2 > .05]. In addition, neither drug produced a progressive increase in stereotypy 
across sessions [Cocaine X Day interaction: !:(6, 168) = 1.73, 2 > .05; Morphine X 
Day interaction: !: < 1.00; Morphine x Cocaine x Day interaction: !:(6, I 68) = I. 96, 
p > .05]. 
Rearing: 
The mean number of rears for each of the four pretreatment groups for the 
seven 120 min pretreatment sessions is illustrated in Figure 6. The within session 
activity across twelve 10 min blocks for the four pretreatment groups on Day 1, 4, and 
7 is depicted in Figure 7. A mixed factor analysis of variance was performed on the 
rearing data with drug treatment conditions as between-groups factors and activity 
test sessions as repeated measures (See Appendix A, Table 4). As seen in Figure 6, 
overall, cocaine significantly increased rearing compared to animals not receiving 
cocaine [cocaine effect: !:(I, 28) = 42.97, 2 < .0001]. In addition, as depicted in 
I. 
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Figure 6. Mean number of rears for each of the four pretreatment groups over 







































1 4 7 
BLOCKS OF 10 MINUTES WITHIN EACH SESSION 
Figure 7. Mean number of rears for each of the four pretreatment groups across the twelve 1 O min 
blocks within each of the 120 min pretreatment sessions for days 1, 4, and 7. N ... 
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Figure 7, this cocaine-induced increase in rearing appeared greatest during the early 
blocks and dissipated during these blocks across the seven days [Cocaine x Block 
interaction: .E(l 1, 308) = 29.90, Q < .0001; Cocaine x Day x Block interaction; .E(66, 
1848) = 1.60, Q < .0001]. 
Morphine also significantly increased overall rearing across the seven days 
compared to vehicle rats [morphine effect: E(l, 28) = 4.28, Q < .05], but this increase 
did not vary across days or blocks [Morphine x Day interaction: .E(6, 168) = 0.63, Q > 
.05; Morphine x Block interaction: !:(11, 308) = 0.44, Q > .05 ; Morphine x Day x 
Block interaction: !:(66, 1848) = 0.92, Q > .05]. 
Cocaine Challenge (Day 8) 
Distance Traveled: 
A mixed factor analysis of variance was performed on the mean distance 
traveled data with drug treatment conditions as between-groups factors and blocks 
. . 
within sessi'ons a_s repeated measures (See Appendix A, Table 5). The mean distance 
traveled for the four pretreatment groups following a IO mg/kg challenge injection of 
cocaine is shown in Figure 8 and the within session mean distance traveled activity of 
the pretreatment groups is shown in Figure 9. 
As may be seen in Figure 8, overall, rats pretreated with cocaine were 
significantly more active following a challenge injection of cocaine compared to rats 
with no previous exposure to cocaine [cocaine effect: E(l, 28) = 10.50, Q < .01]. This 
10 MG/KG COCAINE CHALLENGE (DAY 8) 
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Figure 8. Mean distance traveled in cm (± SEM) after a challenge injection of cocaine 
(1 0 mg/kg) for each of the four pretreatment groups over the 120 min session. 
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Figure 9. Mean distance traveled in cm (± SEM) after a challenge injection of cocaine 
(10 mg/kg) for each of the four pretreatment groups across the twelve 10 




cocaine-induced increase in activity decreased across blocks [ cf. Figure 9; block 
effect: !:(11, 308) = 105.48, 2. < .0001; Cocaine x Block interaction: !:(11, 308) = 
2.84, 2. < .01]. In addition to cocaine, overall, rats pretreated with morphine (i.e., 
Morphine-Vehicle group and the Morphine-Cocaine group) were significantly more 
active following a challenge injection of cocaine than rats pretreated with vehicle (i.e., 
Vehicle-Vehicle and the Vehicle-Cocaine) [morphine effect: !:(1, 28) = 4.69, 2. < 
.05]. The Morphine x Cocaine interaction was not significant, 2. = 0.96. Thus, both 
morphine and cocaine pretreatment produced a subsequent increase in sensitivity to 
cocaine. However, a planned comparison between the vehicle/cocaine and the 
morphine/cocaine pretreated groups revealed no significant differences in distance 
traveled following the cocaine challenge iajection [t(14) = 0.401, p>.05]. Similarly, 
the morphine/cocaine pretreatment did not significantly differ in activity from the 
morphine/vehicle group on this test [t(l4) = 0.143, p>.05]. Thus, although both 
cocaine and morphine pretreatment increased sensitivity to cocaine, the increase was 
not additive. 
Stereotypic Counts: 
The mean stereotypic counts for the four pretreatment groups during the 120 
nun cocaine challenge session are shown in Figure IO and the within session 
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Figure 10. Mean stereotypic counts after a challenge injection of cocaine (10 mg/kg) 
for each of the four pretreatment groups over the 120 min session. 
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Figure 11. Mean stereotypic counts after a challenge injection of cocaine (10 mg/kg) 
for each of the four pretreatment groups. across the twelve 10 min blocks 
within the 120 min session. 
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There were no overall significant differences between the groups. As depicted 
in Figure 11, there was an overall decrease in activity for all groups over the twelve 
10 min blocks [block effect: E(l J, 308) = 97.16, Q < .0001] (See Appendix A, Table 
6). 
Rearing: 
The mean number ofrears for the four pretreatment groups during the 120 min 
cocaine challenge are shown in Figure 12 while the within session mean number of 
rears for the four pretreatment groups is illustrated in Figure I 3. Like stereotypy, 
there were no overall significant differences between the groups. However, animals 
pretreated with cocaine appeared to be more active than animals with no previous 
exposure to .cocaine; on- some blocks [block effect E(l I, 308) = 63.04, Q < .0001; 

























Figure 12. Mean number of rears after a challenge injection of cocaine (10 mg/kg) 
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Mean number of rears after a challenge injection of cocaine (10 mg/kg) 
for each of the four pretreatment groups across the twelve 1 0 min blocks 




Previous research has examined behavioral sensitization through two distinct 
methods. First, the observation that injections of a psychostimulant lead to a 
progressive increase in the dependent measure, typically locomotion, demonstrates 
behavioral sensitization. An additional technique to measure behavioral sensitization 
has been to compare animals exposed to a drug versus animals with no previous drug 
exposure after a "challenge" injection of the drug. To demonstrate sensitization, the 
pre-exposed drug group should display a significantly augmented behavioral response 
to the challenge iajection when compared to the group that received no prior drug 
experience. Indeed, several studies have used both methods of demonstrating 
behavioral sensitization. 
The current study investigated the development and expression of behavioral 
sensitization via• the two pre_viously described measures over three dependent 
measures: distance traveled, rearing, and stereotypy. 
I. Behavioral sensitization to cocaine 
Consistent with previous research, animals receiving cocaine displayed an 
increase in mean distance traveled from day I to day 7 (e.g., sensitization) (Mattingly 
et al., 1994; Mattingly et al., 1996; Stewart & Badiani, 1993) but not on the other 
dependent measures. In addition, on day 8, animals with pre-exposure to cocaine 
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demonstrated a significantly greater response only on one dependent measure, mean 
distance traveled, to the cocaine challenge compare to vehicle treated animals 
(Mattingly et al., 1994; Mattingly et al., 1996). 
II. Behavioral sensitization to morphine 
Surprisingly, animals that received morphine did not show the same 
progressive increase in activity over the seven pretreatment days as animals that 
received cocaine did. However, animals that received morphine pretreatments 
demonstrated a greater response in mean distance traveled on the cocaine challenge 
test compared to animals that did not receive morphine during pretreatment, 
suggesting morphine produced cross-sensitization to cocaine. This finding is 
consistent with previous literature that demonstrates that dopamine agonists (i.e., 
cocaine and amphetamine) cross-sensitize to morphine (Vanderschuren et al., 1997; 
Vandershuren et al., 1999; Vezina et al., 1989). In addition, the increased response to 
cocaine present in animals that received morphine during pretreatment suggests that 
cocaine and morphine may have similar physiological effects. 
III. Effect of the combination of cocaine and morphine 
As mentioned previously, research has demonstrated that the combined 
administration of cocaine and a mu opioid agonist may increase the behavioral and 
rewarding effects of these drugs compared to either drug singularly (Kunko et al., 
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1998; Kimmel et al., 1997b; Rowlett & Wolverton, 1997; Rowlett et al., 1998; 
Duvauchelle et al., 1998). Indeed, the main purpose of the current experiment was to 
determine whether the combination of cocaine and morphine interact and activate 
locomotor activity in an additive or synergistic way. The results of this study suggest 
that the combination of cocaine and morphine do not act in an additive way. During 
the pretreatment phase, the addition of cocaine to morphine did not increase the mean 
distance traveled compared to animals that received only morphine. Additional 
evidence is provided by the day 8 cocaine challenge day. Indeed, on day 8, the 
combination of the two drugs, cocaine and morphine, did not significantly increase 
activity beyond either drug alone. This finding is consistent with previous research in 
which doses of cocaine and morphine, individually subthreshold for the induction of 
behavioral sensitization, did not co~bine in an additive manner (Mattingly et al., 
. / 
1999). 
IV. Summary and conclusions 
As noted previously, cocaine and opioid agonists are commonly abused in a 
drug combination known as "speedball" (Kosten et al., 1986). At present, little is 
known of the behavioral and neuropharmacological mechanisms mediating the 
attractiveness of the drug combination. Evidence from clinical studies suggests that 
stimulant/opioid combinations may enhance the euphoric effects of each drug and/or 
attenuate the negative side effects of each drug (Hunt et al., 1984; Strug et al., 1985). 
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At present, conflicting evidence exists in the preclinical studies with rats and 
monkeys. Although some studies have reported an enhanced reinforcing effect of 
stimulant/opioid combinations compared to either drug alone (Rowlett & Woolverton, 
1997; Duvauchelle, Sapoznik, & Kornetsky, 1998; Ranaldi & Wise, 2000), others 
have reported no significant enhancements (Mello et al., 1995). Similarly, the 
subjective effects of stimulant and opioid compounds do not appear to be additive as 
measured by drug discrimination tasks (Lamas et al., 1998; Negus et al., 1998a; 
Negus et al., 1998b). Taken together, these findings suggest that the attractiveness 
and abuse liability of speedball combinations is not simply due to enhancement of 
each drugs subjective and reinforcing effects. 
The present findings are consistent with this conclusion. That is, although 
repeated morphine treatments produced cross-sensitization to cocaine, the addition of 
morphine to cocaine did not enhance the development of behavioral sensitization to 
cocaine. This finding is consistent with previous literature in this laboratory using 
combinations of doses of cocaine and morphine subthreshold for the development of 
behavioral sensitization (Mattingly et al., 1999). 
To the extent that the development of behavioral sensitization is a valid model 
for the induction of craving (see Robinson & Berridge, 1993; Robinson & Berridge, 
2000; Robinson & Berridge, 200 I), the current findings suggest the combination of 
cocaine and morphine does not induce any greater craving than either drug alone. 
However, additional research is needed to further evaluate the long-term effects of 
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this drug combination. For example, the current study used a short pretreatment 
phase (7 days) and a short withdrawal interval (24 hrs). Sensitization to either 
cocaine or morphine, however is known to persist for weeks or months following 
drug withdrawal. Whether the combination of cocaine and morphine would affect the 
long-term persistence of behavioral sensitization is unknown. 
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Summary of Analysis of Variance Performed on Mean 
Distance Traveled: Pretreatment Days 1-7 
Source Of MS F nu 
Between Groups 
Morphine (M) I 10860594 9.71 *** 0.26 
Cocaine (C) 1 37355314 33.41 **** 0.54 
MxC 1 5300087 4.74* 0.14 
Error 28 1118212 
Within Groups 
Day (D) 6 550527 3.01** 0.10 
MxD 6 230568 1.26 0.04 
CxD 6 662735 3.63** 0.11 
MxCxD 6 223666 1.22 0.04 
Error 168 182747 
Block (B) 11 24358653 248.36**** 0.90 
MxB 11 155296 1.58 0.05 
CxB 11 4723013 48.15**** 0.63 
MxCxB 11 96765 0.99 0.03 
Error 308 98080 
DxB 66 42358 1.32* 0.05 
MxDxB 66 44220 1.38* 0.05 
CxDxB 66 87069 2.72**** 0.09 
MxCxDxB 66 23397 0.73 0.03 







Summary of Analysis of Variance Performed on Mean 
Stereotypic Count: Pretreatment Days 1-7 
Source Of MS F nu 
Between Groups 
Morphine (M) I 45379113 19.72**** 0.41 
Cocaine (C) 1 94534878 41.08**** 0.59 
MxC I 20403107 8.87** 0.24 
Error 28 2301080 
Within Groups 
Day (D) 6 269548 0.57 0.02 
MxD 6 439401 0.93 0.03 
CxD 6 812547 1.73 0.06 
MxCxD 6 921707 1.96 0.07 
Error 168 470170 
Block (B) 11 58467039 364.48**** 0.93 
MxB 11 353557 2.20** 0.07 
CxB 11 5612641 34.99**** 0.56 
MxCxB 11 632003 3.94**** 0.12 
Error 308 160414 
DxB 66 223347 2.30**** 0.08 
MxDxB 66 108511 1.12 0.04 
CxDxB 66 110593 1.14 0.04 
MxCxDxB 66 106842 1.10 0.04 







Summary of Analysis of Variance Performed on Mean 
Number of Rears: Pretreatment Days 1-7 
Source Df MS F ' nu-
Between Groups 
Morphine(M) 1 15405 4.28* 0.13 
Cocaine (C) I 154533 42.97**** 0.61 
MxC I 7577 2.11 0.07 
Error 28, J597 
Within Groups ~ ; 
Day (D) 6" 4034 5.28**** 0.16 
MxD 6 484 0.63 0.02 
CxD 6 1189 1.56 0.05 
MxCxD 6 2499 3.27** 0.10 
Error 168 764 
Block (8) 11 89016 180.09**** 0.87 
MxB 11 219 0.44 0.02 
CxB 11 14780 29.90**** 0.52 
MxCxB 11 699 1.42 0.05 
Error 308 494 
DxB 66 701 4.67**** 0.14 
MxDxB 66 138 0.92 0.03 
CxDxB 66 241 1.60**** 0.05 
MxCxDxB 66 174 1.16 0.04 







Summary of Analysis of Variance Performed on Mean 
Distance Traveled: Cocaine Challenge Day 8 
Source Df MS F nu 
Between Groups 
Morphine (M) 1 788692 4.69* 0.14 
Cocaine (C) 1 17666395 10.50** 0.27 
MxC I 161270 0.96 0.03 
Error 28 168271 
Within Groups 
Block (B) 11 5743693 105.48**** 0.79 
MxB 11 28758 0.53 0.02 
CxB 11 154499 2.84** 0.09 
MxCxB 11 26452 0.49 0.02 







Summary of Analysis of Variance Performed on Mean 
Stereotypic Count: Cocaine Challenge Day 8 
Source Df MS F mr 
Between Groups 
Morphine (M) I 1807445 3.20 0.10 
Cocaine (C) I 1038232 1.84 0.06 
MxC I 542327 0.96 0.03 
Error 28 565079 
Within Groups 
Block (B) 11 10481411 97.16**** 0.78 
MxB 11 38128 0.35 0.01 
CxB 11 114071 1.06 0.04 
MxCxB 11 108786 1.01 0.03 







Summary of Analysis of Variance Performed on Mean 
Number of Rears: Cocaine Challenge Day 8 
Source Df MS F nu 
Between Groups 
Morphine (M) I 546 0.56 0.02 
Cocaine (C) I 1276 1.30 0.04 
MxC 1 748 0.76 0.03 
Error 28 982 
Within Groups 
Block (B) 11 10607 63.04**** 0.69 
MxB 11 89 0.53 0.02 
CxB 11 408 2.42** 0.08 
MxCxB 11 90 0.54 0.02 








Squad# Subject# Pretreatment Group Chamber# 
1 1 Vehicle-Vehicle I 
I 2 Vehicle-Cocaine 2 
1 3 Morphine-Vehicle 3 
I 4 Morphine-Cocaine 4 
2 5 Morphine-Vehicle I 
2 6 Morphine-Cocaine 2 
2 7 Vehicle-Vehicle 3 
2 8 Vehicle-Cocaine 4 
3 9 Vehicle-Cocaine I 
3 10 Vehicle-Vehicle 2 
3 11 Morphine-Cocaine 3 
3 12 Morphine-Vehicle 4 
4 13 Morphine-Cocaine I 
4 14 Morphine-Vehicle 2 
4 ,15 Vehicle-Cocaine 3 
4 16' Vehicle-Vehicle 4 
5 17 Vehicle-Vehicle I 
5 18 Vehicle-Cocaine 2 
5 19 Morphine-Vehicle 3 
5 20 Morphine-Cocaine 4 
6 21 Morphine-Vehicle I 
6 22 Morphine-Cocaine 2 
6 23 Vehicle-Vehicle 3 
6 24 Vehicle-Cocaine 4 
7 25 Vehicle-Cocaine I 
7 26 Vehicle-Vehicle 2 
7 27 Morphine-Cocaine 3 
7 28 Morphine-Vehicle 4 
8 29 Morphine-Cocaine I 
8 30 Morphine-Vehicle 2 
8 31 Vehicle-Cocaine 3 
8 32 Vehicle-Vehicle 4 
